Biodesix

Biodesix, Inc. is a leading molecular diagnostics company specializing in the development and commercialization of non-invasive blood-based tests for lung diseases, including lung cancer. They generate revenue through the sale of their diagnostic tests, which aid in the early detection, diagnosis, and treatment of lung conditions, as well as through partnerships and collaborations with pharmaceutical companies. Founded in 2005, Biodesix has a history of innovation in personalized medicine, leveraging advanced technologies such as proteomics and genomics to improve patient outcomes.

Recent Posts by Biodesix

1-20 of 77